KarXT safety study with anti-nausea meds in healthy volunteers
Treatments studied
This trial checks if adding anti-nausea drugs to a new medication (KarXT) is safe for healthy people. It involves a 3-week stay in a research center so doctors can monitor you closely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in good overall health, with no serious medical conditions.
- You must be willing to stay in a research center for about 3 weeks.
- Your body mass index (BMI) must be between 18 and 40.
- If you can get pregnant, you must agree to use birth control.
- You should not have a history of alcohol or drug abuse in the last year.
- No serious eye, stomach, or bladder problems (like glaucoma, stomach blockages, or trouble urinating).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how the drug KarXT is processed in the body based on your CYP2D6 metabolism type. It helps researchers understand if different metabolizer types affect how the drug works and is cleared.
This study is testing new versions of a drug (called KarX and KarT) in healthy adults to see how the body handles them. Researchers will also look at how food affects the drug when taken multiple times.
This trial tests if a new medicine, KarXT, can safely and effectively treat schizophrenia in adolescents. It may help teenagers who have active symptoms like hallucinations or disorganized thinking.
This trial tests a new injectable form of KarXT for schizophrenia. It aims to see if the medicine is safe, tolerable, and how it works in the body.
This study tests a new medicine (KarXT) for schizophrenia, focusing on how it affects urological (bladder and urinary) safety. You'll stop your current antipsychotic and take the study drug to see if it works well and is safe for your urinary system.
This study is testing the safety and effectiveness of a new medication called KarXT for adults with schizophrenia. Participants will take the medication as part of their regular care, and researchers will track how well it works and any side effects.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.